We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Acceptable naming, presentation and packaging of nicotine-containing electronic cigarettes and refill containers.
Guidance on how Pharmacy First will help pharmacies support their communities, with information on the new clinical pathways and fee structure.
The UK government has introduced the Northern Ireland MHRA Authorised Route (NIMAR). This new route for supply became operational 1 January 2022.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
How the supply of medical devices from Great Britain into Northern Ireland works.
Which product type to select when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
This guidance sets out the clinical requirements based on the consensus of what is ‘minimally acceptable’ performance in the opinion of the anaesthesia and intensive care medicine professionals and medical device regulators.
Every year MHRA receives requests for its staff to speak at conferences and other events across the world.
Ten guiding principles that can inform the development of Good Machine Learning Practice (GMLP).
How to test and report levels of nicotine uptake when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
Report on the service providing sterile, controlled environments for the preparation of injectable medicines into ready-to-administer formats for patients.
The way you apply to licence biological products has changed
How and when to register updated packaging and information leaflets when new national marketing authorisations have been issued
Report on the public health impact of nurses and midwives, dentists, allied health professionals and pharmacists.
Guidance for dispensing of valproate-containing medicines in the manufacturer’s original full pack, following amendments to the Human Medicines Regulations (HMRs).
The Coordinated pathway process resumed Monday 22 May 2023.
This external quality assessment (EQA) scheme is suitable for laboratories that routinely test for a range of food-borne pathogens and indicator organisms.
The review of the safety of isotretinoin has concluded.
Information for patients, healthcare professionals and the wider public to help better understand the importance of AAIs as a potential life-saving medicine.
A taxonomy of different incident types, modalities and outcomes in clinical imaging, MRI and nuclear medicine.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).